Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00269087
Status:
COMPLETED
Last Update Posted:
2019-02-01
First Post:
2005-12-21
Brief Title:
GW815SF For Chronic Obstructive Pulmonary Disease Chronic Bronchitis Emphysema
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
Clinical Evaluation of GW815SF for Chronic Obstructive Pulmonary Disease Chronic Bronchitis Emphysema A Long-term Treatment Study of GW815SF50500µg in Chronic Obstructive Pulmonary Disease -
Status:
COMPLETED
Status Verified Date:
2018-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study evaluates the safety of medicine on COPD Chronic Obstructive Pulmonary Disease This study will last up to 56 weeks and subjects will visit the clinic 16 times Subjects will be given breathing tests and will record their breathing symptoms daily on diary cards
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None